Intensified case finding for tuberculosis in prevention of mother-to-child transmission programs: A simple and potentially vital addition for maternal and child health

Journal of Acquired Immune Deficiency Syndromes

Volumn 50, Issue 2, 2009, Pages 196-199

  Deluca, Andrea ^a   Chaisson, Richard E ^a,c   Martinson, Neil A ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c Center for TB Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ISONIAZID; TUBERCULOSTATIC AGENT;

CASE FINDING; CHILDHOOD MORTALITY; DISEASE ASSOCIATION; EXTRAPULMONARY TUBERCULOSIS; GROUPS BY AGE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; MATERNAL MORBIDITY; MATERNAL MORTALITY; MATERNAL WELFARE; NOTE; PATIENT COUNSELING; PREGNANCY; PRENATAL CARE; PRENATAL SCREENING; PRIORITY JOURNAL; PUERPERIUM; SEX DIFFERENCE; SHORT COURSE THERAPY; TUBERCULIN TEST; TUBERCULOSIS; VERTICAL TRANSMISSION; ADOLESCENT; ADULT; AFRICA; AGED; ARTICLE; CHILD WELFARE; DISEASE TRANSMISSION; FEMALE; INFANT; INFECTION CONTROL; MALE; MIDDLE AGED; NEWBORN; PREGNANCY COMPLICATION; PRESCHOOL CHILD; PROGRAM DEVELOPMENT;

ADOLESCENT; ADULT; AFRICA; AGED; CHILD WELFARE; CHILD, PRESCHOOL; DISEASE NOTIFICATION; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MATERNAL WELFARE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROGRAM DEVELOPMENT; TUBERCULOSIS; YOUNG ADULT;

EID: 60749109553     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181900201     Document Type: Note

References (32)

1. Mashego M, Johnson D, Frohlich J, et al. High AIDS-related mortality among young women in rural KwaZulu-Natal. S Afr Med J. 2007;97:587-592.
2. Mofenson L, Laughon B. Human immunodeficiency virus, Mycobacterium Tuberculosis, and pregnancy: a deadly combination. Clin Infect Dis. 2007;45:250-253.
3. Corbett EL, Marston B, Churchyard GJ, et al. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet. 2006;267:926-937.
4. Maher D, Harries A, Getahun H. Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies. Trop Med Int Health. 2005;10:734-742.
5. Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients coinfected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006;368:1575-1580.
6. De Cock KM, Chaisson RE. Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection. Int J Tuberc Lung Dis. 1999;3:457-465.
7. Kail PB, Gray GE, Violari A, et al. Combining PMTCT with active case finding for tuberculosis. J Acquir Immune Defic Syndr. 2006;42:379-381.
8. Nachega J, Coetzee J, Adendorff T, et al. Tuberculosis active case-finding in a mother-to-child transmission prevention programme in Soweto, South Africa. AIDS. 2003;17:1398-1400.
9. Pillay T, Khan M, Moodley J, et al. Perinatal tuberculosis and HIV-1: considerations for resource-limited settings. Lancet Infect Dis. 2004;4:155-159.
10. World Health Organization. Global Tuberculosis Control: Surveillance, planning, financing. WHO Report. 2008. Geneva, World Health Organization, WHO/HTM/2008.393. Available at: http://www.who.int/tb/ publications/global_report/2008/pdf/annex3_afr.pdf. Accessed April 11, 2008.
11. Khan M, Pillay T, Moodley JM, et al, and Durban Perinatal TB HIV-1 Study Group. Maternal mortality associated with tuberculosis-HIV-1 co-infection in Durban, South Africa. AIDS. 2001;15:1857-1863.
12. National Institute on Allergy and Infectious Diseases. Fact Sheet: HIV infection in women. Available at: http://www.niaid.nih.gov/factsheets/womenhiv. htm. Accessed December 8, 2006.
13. Auvert B, Buve A, Ferry B, et al. Ecological and individual level analysis of risk factors for HIV infection in four urban populations in sub-Saharan Africa with different levels of HIV infection. AIDS. 2001;15:S15-S30.
14. Espinaoza L, Hall I, Hardnett F, et al. Characteristics of persons with heterosexually acquired HIV infection, United States 1999-2004. Am J Public Health. 2007;97:144-149.
15. Joint United Nations Programme on HIV/AIDS, World Health Organization. AIDS Epidemic Update, December 2006. Geneva. UNAIDS/06.29E. Available at: http://www.who.int/hiv/mediacentre/2006_GR_ ANN1A-L_en.pdf. Accessed November 26, 2008.
16. United Nations Development Reports. World Population Prospects 1950-2050: The 2006 Revision. Database. New York, NY: Department of Economic and Social Affairs, Population Division; 2007. Available at: http://hdrstats.undp.org/indicators/48.html. Accessed May 23, 2008.
17. Hill K, Thomas K, AbouZahr C, et al. Estimates of maternal mortality worldwide between 1990 and 2005: an assessment of available data. Lancet. 2007;370:1311-1319.
18. McIntyre J. Maternal health and HIV. Reprod Health Matters. 2005;13:129-135.
19. Mataka E. Maternal health and HIV: bridging the gap. Lancet. 2007;370:1290-1291.
20. Pillay T, Khan M, Moodley J, et al. The increasing burden of tuberculosis in pregnant women, newborns, and infants under 6 months of age in Durban, KwaZulu-Natal. S Afr Med J. 2001;91:983-987.
21. Gupta A, Nayak U, Ram M, et al. Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005. Clin Infect Dis. 2007;45:241-249.
22. Edwards DJ, Kitetele F, Van Rie A. Agreement between clinical scoring systems used for the diagnosis of pediatric tuberculosis in the HIV era. Int J Tuberc Lung Dis. 2007;11:263-269.
23. M'Pemba Loufoua Lemay AB, Mabiala Babela JR, Bantsimba T, et al. Tuberculosis and HIV/AIDS co-infection in children: experience carried out in a paediatric service of the teaching hospital of Brazzaville, Republic of Congo (1995-2004). Bull Soc Pathol Exot. 2007;100:51-52.
24. Marais BJ, Graham SM, Cotton MF, et al. Diagnostic and management challenges for childhood tuberculosis in the era of HIV. J Infect Dis. 2007;196:S76-S85.
25. Chintu C. Tuberculosis and human immunodeficiency virus co-infection in children: management challenges. Paediatr Respir Rev. 2007;8:142-147.
26. Kumar A, Upadhyay S, Kumari G. Clinical presentation, treatment outcome and survival among the HIV infected children with culture confirmed tuberculosis. Curr HIV Res. 2007;5:299-504.
27. Golub J, Mohan CI, Comstock GW, et al. Active case finding of tuberculosis: historical perspective and future prospects. Int J Tuberc Lung Dis. 2005;9:1183-1203.
28. Kruk A, Gie RP, Schaaf HS, et al. Symptom-based screening of child tuberculosis contacts: improved feasibility in resource-limited settings. Pediatrics. 2008;121:e1646-e1652.
29. Day JH, Charalambous S, Fielding KL, et al. Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa. Int J Tuberc Lung Dis. 2006;10:523-529.
30. Kimerling ME, Schuchter J, Chanthol E, et al. Prevalence of pulmonary tuberculosis among HIV-infected persons in a home care program in Phnom Penh, Cambodia. Int J Tuberc Lung Dis. 2002;6:988-994.
31. Mohammed A, Ehrlich R, Wood R, et al. Screening for tuberculosis in adults with advanced HIV infection prior to preventive therapy. Int J Lung Dis. 2004;8:792-795.
32. CDC. Targeted tuberculin testing and treatment of latent tuberculosis infection. ATS/CDC statement committee on latent tuberculosis infection, June 2000. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr4906a1.htm. Accessed July 11, 2008.